2.82
-0.17(-5.69%)
Currency In USD
| Previous Close | 2.99 |
| Open | 2.96 |
| Day High | 3 |
| Day Low | 2.79 |
| 52-Week High | 9.97 |
| 52-Week Low | 2.79 |
| Volume | 853,837 |
| Average Volume | 4.2M |
| Market Cap | 362.84M |
| PE | -2.1 |
| EPS | -1.34 |
| Moving Average 50 Days | 4.1 |
| Moving Average 200 Days | 5.47 |
| Change | -0.17 |
If you invested $1000 in Humacyte, Inc. (HUMA) since IPO date, it would be worth $309.2 as of March 13, 2025 at a share price of $2.99. Whereas If you bought $1000 worth of Humacyte, Inc. (HUMA) shares 3 years ago, it would be worth $547.62 as of March 13, 2025 at a share price of $2.99.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Humacyte Announces Publication of the Budget Impact Model (BIM) for Symvess™ (acellular tissue engineered vessel-tyod) in the Journal of Medical Economics
GlobeNewswire Inc.
Mar 10, 2025 12:00 PM GMT
– Symvess is a first-in-class bioengineered human tissue designed to be a universally implantable vascular conduit for use in arterial replacement and repair – – Publication of the Budget Impact Model in peer-reviewed journal supports Symvess as a tr
Humacyte to Host In-Person and Virtual Investor Event in New York to Discuss Commercial Launch of Symvess™ (acellular tissue engineered vessel-tyod) for Extremity Vascular Trauma on March 6, 2025
GlobeNewswire Inc.
Mar 03, 2025 1:00 PM GMT
DURHAM, N.C., March 03, 2025 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, today announced it will host an i
Humacyte to Present at the TD Cowen 45th Annual Health Care Conference
GlobeNewswire Inc.
Feb 27, 2025 9:05 PM GMT
DURHAM, N.C., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, today announced that Laura Niklaso